Nearly all COVID-19 deaths and hospitalizations in the U.S. are among unvaccinated people, according to federal officials. White House coronavirus response coordinator Jeff Zients said cases will likely rise among states with large numbers of unvaccinated people, especially as the Delta variant spreads. (CNBC Weekly)

In the wake of criticism over Aduhelm’s approval, Biogen announced Thursday it will narrow the Alzheimer drug’s label. It will now state that Aduhelm can be given to patients with mild cognitive impairment due to Alzheimer’s disease or mild Alzheimer’s dementia. (Endpoints News)

Fifteen states, including Massachusetts and New York, have reached an agreement with Purdue Pharma around a potential $4.5 billion settlement over the company’s marketing of opioids. The states dropped their opposition to Purdue’s bankruptcy reorganization plan for an extra $50 million. (The New York Times)

Voice health tracking startup Sonde is partnering with Qualcomm to help bring its technology to smartphones. Sonde aims to use voice characteristics to detect symptoms of various conditions, including asthma and COVID-19. (STAT)

Disparities in state vaccination rates remain, with some states lagging far behind Biden’s original 70% vaccination goal by July 4. Many southern states, such as Tennessee and Mississippi, have vaccination rates closer to 50% or 60%. (Kaiser Health News)